Hanmi Science Stock: Unpacking the Major Share Sale Concerns are rising among investors following the news of a significant stake sale by Hanmi Science’s largest shareholder and related parties on August 29, 2025. Let’s delve into the details of this sale, its potential impact on the stock price, and the steps investors should consider. 1. … Read more
Hanmi Science CEO’s Stake Sale: A Cause for Concern? On August 29, 2025, Hanmi Science CEO Lim Jong-yoon sold a substantial portion of his shares. Is this a simple portfolio adjustment, or a sign of impending management changes? We analyze the reasons behind this stake sale, its potential impact on the market, and the key … Read more
EM Korea Exits Machine Tool Business: Impact on Stock Price EM Korea has announced the closure of its Haman plant and its withdrawal from the machine tool OEM business. What impact will the withdrawal from this significant revenue stream have on the company’s future? This article analyzes the opportunities and threats behind EM Korea’s strategic … Read more
WSI, Major Shareholder Divests Large Stake! What Should Investors Do? On August 29, 2025, WSI’s largest shareholder sold a significant portion of their stake. This news shocked investors and increased uncertainty about the stock’s future direction. How will this divestment impact the company’s future? This article analyzes WSI’s business status, financial condition, and the implications … Read more
MECARO, Special Relationship Shareholding Change! Is it a Chance or a Crisis? Recent disclosure of changes in shareholding by a special relationship party of MECARO is drawing attention from investors. How will this change affect MECARO’s stock price? This article analyzes the hidden investment value of MECARO and presents future investment strategies. Check out the … Read more
JEIL M&S, Red Flags for Investment? JEIL M&S (412540), once a promising player in the secondary battery mixing equipment industry, is facing a severe crisis. The 2025 semi-annual report reveals shocking details including a sharp drop in sales, massive losses, and complete capital impairment. Investors need to understand these key findings, the future outlook, and … Read more
Pino’s $7.9B Copper Deal: A Game-Changer for Battery Materials? Battery materials company Pino has just secured a significant $7.9 billion copper supply contract, potentially fueling its ambitious growth trajectory. This article delves into the contract’s implications, highlighting key opportunities and risks for investors interested in this burgeoning sector. 1. Decoding the $7.9 Billion Copper Deal … Read more
Chong Kun Dang Enters the Hypertension Treatment Market: Should Investors Pay Attention to Telminuvo’s Approval? Chong Kun Dang’s newly developed hypertension treatment, Telminuvo, has received approval from the Ministry of Food and Drug Safety (MFDS). How will this news impact Chong Kun Dang Holdings’ stock price? This article delves into the significance of Telminuvo’s approval, … Read more
Korea BioNics’ Partial Vienox Lawsuit Win: An Investor Analysis Korea BioNics recently achieved a partial victory in the Vienox lawsuit. What implications does this hold for the company’s future? In this article, we delve into the significance of the ruling, analyze Korea BioNics’ fundamentals, and explore potential investment strategies. Read on to find out more. … Read more
Graphi: Poised for Growth or Facing Financial Peril? Graphi, a company making waves with its innovative shape memory transparent orthodontic device (SMA), has recently debuted on the KOSDAQ. However, its post-IPO financials have painted a concerning picture, leaving investors grappling with a crucial question: Does Graphi’s groundbreaking technology outweigh its significant financial challenges? This article … Read more